NR4A1 and breast carcinoma: The clinical characteristics including age, race, ethnicity, tumor grade and hormone receptor status were compared between TCGA and GENIE breast cancer invasive lobular carcinomas (ILC) and invasive ductal carcinomas (IDC) patients (Table 1).